Weekly Rundown: World-first lung cancer vaccine enters clinical trials Rare disease approvals, multi-billion-dollar deals, and more led this week’s headlines. ++++

https://www.drugdiscoverynews.com/weekly-rundown-world-first-lung-cancer-vaccine-enters-clinical-trials-16817 Why is tuberculosis still a global challenge? A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story. https://www.drugdiscoverynews.com/why-is-tuberculosis-still-a-global-challenge-16811 Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals These latest deals give Lilly a complementary portfolio of life-changing therapies and scalable gene therapy platforms. https://www.drugdiscoverynews.com/lilly-strengthens-gene-therapy-portfolio-with-meiragtx-and-adverum-deals-16816 Quantum techniques offer a glimpse of next-generation medicine Quantum-informed AI could open up unexplored chemical space, speeding the design of safer, more effective drugs. https://www.drugdiscoverynews.com/quantum-techniques-offer-a-glimpse-of-next-generation-medicine-16815